Form 4: SelectQuote Executive Ryan Souan Receives Stock Grants
SEC Form 4 Filing
Ryan Souan, an officer of SelectQuote, Inc., was granted restricted stock units and price-vested restricted stock units under the company's 2020 Omnibus Incentive Plan.
Summary
- On October 28, 2024, Ryan Souan, an officer of SelectQuote, Inc., received grants of restricted stock units (RSUs) and price-vested restricted stock units (PVUs).
- A total of 39,501 RSUs were granted, vesting in three annual installments starting August 1, 2025, contingent upon continued employment.
- An additional 39,501 PVUs were granted, also vesting in three annual installments commencing August 1, 2025, subject to continued employment.
- The PVUs vest based on the 60-day average closing price of SelectQuote's common stock exceeding $3.13, $6.00, and $9.00 during a five-year performance period.
Sentiment
Score: 6
Explanation: The document itself is neutral, simply reporting a routine equity grant. The sentiment is slightly positive as it indicates continued investment in key personnel.
Positives
- The grants of RSUs and PVUs align executive compensation with the company's long-term performance.
- The vesting schedules incentivize continued employment and achievement of stock price targets.
Risks
- The value of the RSUs and PVUs is dependent on SelectQuote's stock price, which can be volatile.
- Failure to meet the stock price targets for the PVUs would result in forfeiture of those units.
Future Outlook
The document does not contain any specific forward-looking statements regarding the company's financial performance or future prospects, only the vesting schedule of the granted equity.
Industry Context
Equity grants are a common practice in the industry to incentivize and retain key personnel. The specific terms of the grants, such as vesting schedules and performance targets, are tailored to the company's specific goals and circumstances.
Comparison to Industry Standards
- Equity compensation is a standard practice across publicly traded companies, particularly in the technology and healthcare sectors where SelectQuote operates.
- Companies like eHealth, Inc. and GoHealth, Inc., which are SelectQuote's competitors, also utilize stock options and restricted stock units as part of their compensation packages.
- The vesting schedules and performance metrics associated with these grants are generally aligned with industry norms, aiming to incentivize long-term value creation and retention of key talent.
Stakeholder Impact
- The equity grants could potentially align the officer's interests with those of shareholders, incentivizing them to increase company value.
- Employees may view the equity grants as a positive sign of the company's commitment to its leadership.
Key Dates
| Date | Description |
|---|---|
| 10/28/2024 | Date of transaction: Grant of restricted stock units and price-vested restricted stock units. |
| 08/01/2025 | First vesting date for both restricted stock units and price-vested restricted stock units. |
| 10/28/2034 | Expiration date for the restricted stock units and price-vested restricted stock units. |
| 10/30/2024 | Date of filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.